Drug firm Zydus Cadila said on February 2 that it has started supply like him COVID-19 Vaccine ZyCoV-D to the Central Government.
The pharmaceutical company said in a statement that the company has started the supply as per the order given by the government.
The group is also planning to make the vaccine available in the private market.
ZyCoV-D is a three-dose vaccine that is administered intravenously.
“The vaccine will cost ₹265 per dose and the applicant will be offered ₹93 per dose excluding GST,” zydus cadilla said.
The Ahmedabad-based drugmaker has entered into a definitive agreement with Shilpa Medicare Ltd, a contract manufacturing organisation, to produce a mutually agreed dosage of ZyCoV-D.
Zydus Cadila said it has entered into an agreement with Enzyme Lifesciences of the Republic of Korea for a manufacturing license and technology transfer for the plasmid DNA vaccine.
ZyCoV-D is a plasmid DNA vaccine that produces the spike protein of the SARS-CoV-2 virus and elicits an immune response mediated by the cellular and humoral arms of the human immune system, which also plays an important role in protection against disease. Is. as viral clearance.
,